After Novo Nordisk breached not one, not two, but seven clauses of the code that regulates U.K. drugmakers, its U.K. general manager is stepping down as president of the industry's national ...

Angelini was ruled in breach of Clause 2 of the 2021 Code in relation to an in-person presentation by a contracted speaker at a company-organised promotional meeting, and its recording, which ...

The move to make pharma more transparent and build a positive reputation is the key theme to come out of the launch of the new ABPI Code of Practice during Code Awareness Week. The move to make pharma ...

On 23rd September, the ABPI released an updated Code of Practice. Their last release was in 2021, and this latest update has been much anticipated. There are no track changes of what has been updated ...

A U.K. pharma trade group suspended Novo Nordisk’s membership for two years after marketing efforts for its obesity drug were deemed a breach of the group’s standards. ABPI said it took the action ...

More detailed requirements for pharmaceutical companies’ relationships with patient groups and health professionals will be included in the revised ABPI Code of Practice which comes into effect on ...

The pharmaceutical company had previously been subjected to a 2-year suspension. The Association of the British Pharmaceutical Industry (ABPI) reinstated Novo Nordisk’s membership in the group. 1 The ...

UK pharmaceutical companies have historically relied upon consent as the lawful basis for the disclosure of healthcare professionals’ personal data relating to transfers of value. However, the low ...